Clinical Trial Details
— Status: Terminated
Administrative data
NCT number |
NCT01511666 |
Other study ID # |
Prague OHCA study |
Secondary ID |
|
Status |
Terminated |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
March 2013 |
Est. completion date |
October 25, 2020 |
Study information
Verified date |
March 2021 |
Source |
Charles University, Czech Republic |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
Prague out-of Hospital Cardiac Arrest (OHCA) study is a prospective randomized multicenter
clinical study comparing use of prehospital intraarrest hypothermia, mechanical chest
compression device, extracorporeal life support (ECLS) and early invasive investigation and
treatment (coronary angiography/percutaneous coronary intervention [PCI]; pulmonary
angiography/percutaneous embolectomy; aortography) in all patients with OHCA of presumed
cardiac origin compared to standard of care. It is hypothesized, that above stated
"hyperinvasive" approach might improve outcome of out-of hospital cardiac arrest victims.
Description:
Background: Out of hospital cardiac arrest (OHCA) has a poor outcome. Recent non-randomized
study of ECLS (extracorporeal life support) in OHCA suggested further prospective multicenter
studies to define population with OHCA that would benefit from ECLS.
Aim: to perform a prospective randomized multicenter clinical study comparing use of
prehospital intraarrest hypothermia, mechanical chest compression device, ECLS and early
invasive investigation and treatment (coronary angiography/percutaneous coronary intervention
[PCI]; pulmonary angiography/percutaneous embolectomy; aortography) in all patients with OHCA
of presumed cardiac origin compared to standard of care.
Planned intervention: patients with witnessed OHCA without ROSC (return of spontaneous
circulation) after a minimum of 5 minutes of ACLS by emergency medical service (EMS) team
will be after fulfilling of inclusion/exclusion criteria for the study randomized in a 1:1
design to standard vs. hyperinvasive arm. Patients in standard arm will be further managed as
per recent guidelines. In hyperinvasive arm, mechanical compression device together with
intranasal cooling will be immediately instituted and patients will be transferred to cardiac
center directly to cathlab under ongoing CPR. After admission to cathlab, overall status,
ROSC and ECLS inclusion/exclusion criteria will be evaluated and in case of no
contraindications to ECLS and no ROSC or ROSC with shock, veno-arterial ECLS will be started
as soon as possible, not later than 60 minutes after cardiac arrest onset. After ECLS
institution, mild hypothermia will be continued by means of ECLS cooling and immediate
invasive investigation will be performed in all patients.
Standard postresuscitation care will follow.